Acerus Pharmaceuticals Corporation and Acerus Pharmaceuticals Corporation
15
Thomas M Horan
01/29/2023
08/31/2023
No
v
| STANDOrder, LEAD, CLOSED |
Assigned to: Honorable Thomas M Horan Chapter 15 Voluntary Debtor disposition: Standard Discharge |
|
Debtor Acerus Pharmaceuticals Corporation
205-7025 Langer Drive Mississauga, ON L5L 1J9 OUTSIDE U. S. Canada Tax ID / EIN: 98-1229465 |
represented by |
Michael Jason Barrie
Benesch Friedlander Coplan & Aronoff LLP 1313 North Market Street Suite 1201 Wilmington, DE 19801 (302) 442-7010 Fax : (302) 442-7012 Email: mbarrie@beneschlaw.com Jennifer R. Hoover
Benesch Friedlander Coplan & Aronoff LLP 1313 North Market Street Suite 1201 Wilmington, DE 19801 302-442-7010 Fax : 302-442-7012 Email: jhoover@beneschlaw.com Steven Walsh
Benesch Friedlander Coplan & Aronoff LLP 1313 North Market Street Suite 1201 Wilmington, DE 19801 302-442-7059 Email: SWalsh@beneschlaw.com |
Foreign Representative Acerus Pharmaceuticals Corporation
205-7025 Langer Drive Mississauga, ON L5L 1J9 OUTSIDE U. S. Canada Tax ID / EIN: 98-1229465 |
represented by |
Michael Jason Barrie
(See above for address) William E. Curtin
Sidley Austin LLP 787 Seventh Avenue . New York, NY 10019 212-839-6745 Fax : 212-839-5599 Email: wcurtin@sidley.com Jennifer R. Hoover
(See above for address) Michael Sabino
SIDLEY AUSTIN LLP 787 Seventh Avenue Email: msabino@sidley.com Michael Sabino
SIDLEY AUSTIN LLP 787 Seventh Avenue New York, NY 10019 (212) 839-5300 Fax : (212) 839-5599 Email: msabino@sidley.com Steven Walsh
(See above for address) |
U.S. Trustee U.S. Trustee
Office of the United States Trustee J. Caleb Boggs Federal Building 844 King Street, Suite 2207 Lockbox 35 Wilmington, DE 19801 (302)-573-6491 |
represented by |
Timothy Jay Fox, Jr.
Office of the United States Trustee U. S. Department of Justice 844 King Street, Suite 2207 Lockbox #35 Wilmington, DE 19801 302-573-6491 Fax : 302-573-6497 Email: timothy.fox@usdoj.gov |
Transcriber Reliable Companies
Attn: Gene Matthews 1007 North Orange Street Suite 110 Wilmington, DE 19801 302-654-8080 |
| Date Filed | # | Docket Text |
|---|---|---|
| 08/31/2023 | Bankruptcy Case Closed (NR) (Entered: 08/31/2023) | |
| 08/29/2023 | 86 | Order Closing the Chapter 15 Cases (related document(s)82, 85) Order Signed on 8/29/2023. (DRG) (Entered: 08/29/2023) |
| 08/28/2023 | 85 | Certificate of No Objection Regarding Final Report of the Foreign Representative and Motion for an Order Closing the Chapter 15 Cases (related document(s)82) Filed by Acerus Pharmaceuticals Corporation. (Hoover, Jennifer) (Entered: 08/28/2023) |
| 07/27/2023 | 84 | Certificate of Service of Final Report of the Foreign Representative and Motion for an Order Closing the Chapter 15 Cases (related document(s)82) Filed by Acerus Pharmaceuticals Corporation. (Attachments: # 1 Exhibit A) (Walsh, Steven) (Entered: 07/27/2023) |
| 07/27/2023 | 83 | Affidavit/Declaration of Service of Final Report of the Foreign Representative and Motion for an Order Closing the Chapter 15 Cases (related document(s)82) Filed by Acerus Pharmaceuticals Corporation. (Walsh, Steven) (Entered: 07/27/2023) |
| 07/26/2023 | 82 | Motion to Approve Final Report of the Foreign Representative and Motion for an Order Closing the Chapter 15 Cases Filed by Acerus Pharmaceuticals Corporation. Objections due by 8/25/2023. (Attachments: # 1 Exhibit A # 2 Exhibit B # 3 Exhibit C # 4 Notice) (Hoover, Jennifer) (Entered: 07/26/2023) |
| 06/20/2023 | 81 | Affidavit/Declaration of Service of Order Recognizing CCA Vesting Order (D.I. 79) and Amended Agenda Cancelling June 15, 2023 Hearing (D.I. 79) (related document(s)78, 79) Filed by Acerus Pharmaceuticals Corporation. (Walsh, Steven) (Entered: 06/20/2023) |
| 06/15/2023 | 80 | Certificate of Service of Notice of Filing of Revised Proposed Order (I) Recognizing and Enforcing the CCAA Vesting Order, (II) Approving the Sale of Substantially All of the Debtors Interests Free and Clear of Liens, Claims, and Encumbrances, and (III) Granting Related Relief; Certification of Counsel Regarding Foreign Representatives Motion for Entry of an Order (I) Recognizing and Enforcing the CCAA Vesting Order, (II) Approving the Sale of Substantially All of the Debtors Interests Free and Clear of Liens, Claims, and Encumbrances, and (III) Granting Related Relief; Order (I) Recognizing and Enforcing the CCAA Vesting Order, (II) Approving the Sale of Substantially All of the Debtors Interests Free and Clear of Liens, Claims, and Encumbrances, and (III) Granting Related Relief; and (iii) (Hearing Cancelled) Notice of Amended Agenda for Hearing Scheduled for June 15, 2023, at 11:00 A.M. (Prevailing Eastern Time), Before the Honorable Thomas M. Horan, Bankruptcy Judge, United States Bankruptcy Court for the District of Delaware, in Courtroom #7 (related document(s)75, 76, 78, 79) Filed by Acerus Pharmaceuticals Corporation. (Walsh, Steven) (Entered: 06/15/2023) |
| 06/13/2023 | 79 | HEARING CANCELLED. Notice of Agenda of Matters not going forward. The following hearing has been cancelled. Filed by Acerus Pharmaceuticals Corporation. Hearing scheduled for 6/15/2023 at 11:00 AM at US Bankruptcy Court, 824 Market St., 3rd Fl., Courtroom #7, Wilmington, Delaware. (Walsh, Steven) (Entered: 06/13/2023) |
| 06/13/2023 | 78 | Order (I) Recognizing and Enforcing the CCAA Vesting Order, (II) Approving the Sale of Substantially All of the Debtors' Interests Free and Clear of Liens, Claims, and Encumbrances, and (III) Granting Related Relief (related document(s)66, 75, 76) Order Signed on 6/13/2023. (Attachments: # 1 Exhibit 1) (AMH) (Entered: 06/13/2023) |